000 01667 a2200445 4500
005 20250517074028.0
264 0 _c20161213
008 201612s 0 0 eng d
022 _a2040-3372
024 7 _a10.1039/c5nr07918g
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aYang, Xiao Xi
245 0 0 _aCurcumin modified silver nanoparticles for highly efficient inhibition of respiratory syncytial virus infection.
_h[electronic resource]
260 _bNanoscale
_cFeb 2016
300 _a3040-8 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAntiviral Agents
_xadministration & dosage
650 0 4 _aCell Line
650 0 4 _aCell Survival
_xdrug effects
650 0 4 _aCurcumin
_xadministration & dosage
650 0 4 _aDrug Carriers
_xchemistry
650 0 4 _aDynamic Light Scattering
650 0 4 _aHumans
650 0 4 _aInterleukin-1beta
_xgenetics
650 0 4 _aInterleukin-6
_xgenetics
650 0 4 _aMetal Nanoparticles
_xchemistry
650 0 4 _aMicroscopy, Fluorescence
650 0 4 _aPhotoelectron Spectroscopy
650 0 4 _aRNA, Messenger
_xmetabolism
650 0 4 _aReal-Time Polymerase Chain Reaction
650 0 4 _aRespiratory Syncytial Virus Infections
_xdrug therapy
650 0 4 _aRespiratory Syncytial Viruses
_xdrug effects
650 0 4 _aSilver
_xchemistry
650 0 4 _aSpectroscopy, Fourier Transform Infrared
650 0 4 _aVirus Internalization
_xdrug effects
700 1 _aLi, Chun Mei
700 1 _aHuang, Cheng Zhi
773 0 _tNanoscale
_gvol. 8
_gno. 5
_gp. 3040-8
856 4 0 _uhttps://doi.org/10.1039/c5nr07918g
_zAvailable from publisher's website
999 _c25643016
_d25643016